2. Academic Validation
  3. Arylsulfonamides as a new class of cannabinoid CB1 receptor ligands: identification of a lead and initial SAR studies

Arylsulfonamides as a new class of cannabinoid CB1 receptor ligands: identification of a lead and initial SAR studies

  • Bioorg Med Chem Lett. 2007 Jan 1;17(1):272-7. doi: 10.1016/j.bmcl.2006.09.049.
N Lambeng 1,  F Lebon,  B Christophe,  M Burton,  M De Ryck,  L Quéré
Affiliations

Affiliation

  • 1 CNS Molecular and Cellular Biology, Centre for CNS Innovation, UCB S.A., Chemin du Foriest, B-1420 Braine L'Alleud, Belgium.
PMID: 17027269 DOI: 10.1016/j.bmcl.2006.09.049
Abstract

High-throughput screening of the UCB sample collection identified the piperidinyl-sulfonyl benzoic ester 1 as a novel agonist for CB(1) receptor with nanomolar affinity. We report here the pharmacological profile of compound 1 as well as preliminary biological activities in pain model. Diverse close analogs of 1 were purchased and the structure-affinity relationships among this novel class are discussed.

Figures
Products